AHCO

AdaptHealth Corp. (AHCO) Economic Moat Analysis (2026)

Invetso Score: 3.4/10 — Weak · Last Updated: 2026-08-01

Overall Score

Pricing Power

Gross margin remains low at 10.4%, indicating limited pricing power in the core business.

Negative EBIT margin of -4.7% suggests the company is still struggling to convert revenue into operating profit.

Scale Efficiency

Asset turnover of 0.69x is modest, but not enough to offset weak profitability.

Operating leverage remains poor, with operating margin near breakeven at -0.3%.

Customer Stickiness

No fresh evidence of stronger retention or recurring demand was provided this month.

The business still appears to lack a clearly visible moat from customer switching costs.

Intangible Assets

Intangibles remain high at 55.3% of total assets, but there is no fresh evidence that they translate into durable moat advantages.

No new product, brand, or regulatory developments were reported this month.

Cost Advantage

SG&A remains elevated at 12.8% of revenue, limiting evidence of a structural cost advantage.

Free cash flow conversion is weak, with FCF only 16.7% of operating cash flow.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on AdaptHealth Corp.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →